HIV/AIDS HAART Prophylaxis
Adherence to HAART prophylaxis is low in victims of suspected sexual abuse
Published in AIDS Vaccine Week, October 31st, 2005
"This study was performed at an urban children's hospital to identify the characteristics of patients given human immunodeficiency virus (HIV) postexposure prophylaxis and describe the adherence and associated side effects of HIV prophylaxis in child and adolescent victims of sexual abuse," scientists writing in the journal Pediatric Emergency Care report.
"A retrospective review of all children presenting for evaluation of suspected sexual abuse who were provided HIV prophylaxis between February 1999 and March 2001 was performed.
"Measured...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Vaccine Week
Source: AIDS Vaccine Week (2005-10-31)
More Articles from AIDS Vaccine Week
- HIV/AIDS Vaccine Development
U.S. NIH launches first phase II trial of HIV/AIDS vaccine - Antimicrobials
Plant extracts have antimicrobial activity against HIV-related fungal pathogens - DNA Research
HIV-1 Vpr induces degradation of UNG and SMUG uracil-DNA glycosylases - HIV/AIDS Coinfection
GBV-C inhibition of HIV mediated by CD4 and CD8 T-cell-derived soluble factors - HIV/AIDS Diagnostics
Plasma RT assay is an affordable alternative for HIV viral load determination - HIV/AIDS Drug Development
Protease inhibitors plus mefloquine have marked synergy against HIV-1 - More from this issue of AIDS Vaccine Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
